STOCK TITAN
  1. Home
  2. Sec-filings
  3. DOC
  4. [Form 4] HEALTHPEAK PROPERTIES, INC. Insider Trading Activity

Director at Healthpeak (NYSE: DOC) receives 9,744 stock units

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Sandstrom Katherine M reported acquisition or exercise transactions in this Form 4 filing.

HEALTHPEAK PROPERTIES, INC. director Katherine M. Sandstrom received an equity award of 9,744 shares of Common Stock on May 6, 2026, recorded at a price of $0.00 per share as a grant rather than an open-market trade. According to the footnote, these restricted stock units vest in full on the earlier of the first anniversary of the May 6, 2026 grant date or the Company's next annual meeting of stockholders. Following this award, Sandstrom directly holds a total of 76,669 shares of the company's stock.

Positive

  • None.

Negative

  • None.
Insider Sandstrom Katherine M
Role null
Type Security Shares Price Value
Grant/Award Common Stock 9,744 $0.00 --
Holdings After Transaction: Common Stock — 76,669 shares (Direct, null)
Footnotes (1)
  1. [object Object]
RSU grant size 9,744 shares Restricted stock unit award on May 6, 2026
Grant price $0.00 per share Equity compensation, non-market transaction
Total holdings after grant 76,669 shares Direct ownership following May 6, 2026 award
Transaction date May 6, 2026 Date of restricted stock unit grant
Restricted stock units financial
"Restricted stock units vest in full on the earlier of the first anniversary"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
grant date financial
"earlier of the first anniversary of the May 6, 2026 grant date"
The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.
annual meeting of stockholders financial
"or the Company's next annual meeting of stockholders"
Grant, award, or other acquisition financial
"transaction_code_description": "Grant, award, or other acquisition""
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Sandstrom Katherine M
(Last)(First)(Middle)
4600 SOUTH SYRACUSE STREET
SUITE 500
(Street)
DENVER COLORADO 80237
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
HEALTHPEAK PROPERTIES, INC. [ DOC ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/06/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/06/2026A9,744(1)A$076,669D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Restricted stock units vest in full on the earlier of the first anniversary of the May 6, 2026 grant date or the Company's next annual meeting of stockholders.
Remarks:
Carol Samaan, SVP, Legal (Attorney-In-Fact)05/07/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did HEALTHPEAK PROPERTIES (DOC) report for Katherine M. Sandstrom?

HEALTHPEAK PROPERTIES reported that director Katherine M. Sandstrom received a grant of 9,744 shares of Common Stock on May 6, 2026. The shares were awarded at $0.00 per share as equity compensation, not as an open-market purchase or sale.

How many HEALTHPEAK PROPERTIES (DOC) shares does Katherine M. Sandstrom hold after this Form 4?

After the May 6, 2026 award, Katherine M. Sandstrom directly holds 76,669 shares of HEALTHPEAK PROPERTIES Common Stock. This total includes the new 9,744-share grant reported in the Form 4 insider transaction filing.

What are the vesting terms of the 9,744 restricted stock units at HEALTHPEAK PROPERTIES (DOC)?

The 9,744 restricted stock units vest in full on the earlier of the first anniversary of the May 6, 2026 grant date or the company’s next annual meeting of stockholders. This single-vesting schedule ties the award to director service over that period.

Was the HEALTHPEAK PROPERTIES (DOC) Form 4 transaction a market buy or sell?

The Form 4 reflects a grant or award acquisition, not a market buy or sell. The 9,744 shares of Common Stock were recorded at $0.00 per share as compensation, meaning no cash changed hands in an open-market transaction.

What does transaction code "A" mean in the HEALTHPEAK PROPERTIES (DOC) Form 4?

Transaction code “A” on the Form 4 indicates a grant, award, or other acquisition of securities. For HEALTHPEAK PROPERTIES, it shows that director Katherine M. Sandstrom received 9,744 shares as a restricted stock unit award rather than buying them in the market.